We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Edwards Lifesciences Sees Strong 2Q Due to Ongoing SAPIEN Adoption
Edwards Lifesciences Sees Strong 2Q Due to Ongoing SAPIEN Adoption
July 26, 2013
Edwards Lifesciences posted strong second quarter results largely due to ongoing growth in sales of transcatheter heart valves, the company revealed in a Thursday earnings report.